Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginger and curcumin co-supplementation is a combination of bioactive extracts derived from *Zingiber officinale* and *Curcuma longa*, respectively. This combination is primarily investigated for its synergistic anti-inflammatory and antioxidant properties. In clinical studies focusing on postmenopausal osteoporosis (PMO), the co-supplementation has demonstrated the ability to improve bone mineral density (BMD) at the femur neck and modulate biochemical markers of bone turnover, such as osteocalcin and alkaline phosphatase. Additionally, it has been shown to reduce systemic inflammatory markers like highly-sensitive C-reactive protein (hs-CRP) and enhance antioxidant defenses by increasing superoxide dismutase (SOD) levels and total antioxidant capacity (TAC).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginger + curcumin.